Dennis D'Andrea - Vice President of Investor Relations Fabrizio Freda - Chief Executive Officer, President and Director Cedric Prouvé - Group President of International Operations Tracey Thomas Travis - Chief Financial Officer, Principal Accounting Officer and Executive Vice President.

Mark S. Astrachan - Stifel, Nicolaus & Company, Incorporated, Research Division Christopher Ferrara - Wells Fargo Securities, LLC, Research Division John A. Faucher - JP Morgan Chase & Co, Research Division Olivia Tong - BofA Merrill Lynch, Research Division Stephen Powers - UBS Investment Bank, Research Division Neely J.N.

Tamminga - Piper Jaffray Companies, Research Division Alice Beebe Longley - The Buckingham Research Group Incorporated Sean King - Goldman Sachs Group Inc., Research Division Ali Dibadj - Sanford C.

Bernstein & Co., LLC., Research Division Wendy Nicholson - Citigroup Inc, Research Division Brian Doyle - CLSA Limited, Research Division Javier Escalante - Consumer Edge Research, LLC William Schmitz - Deutsche Bank AG, Research Division Nik Modi - RBC Capital Markets, LLC, Research Division.

Good day, everyone, and welcome to Estée Lauder Companies Fiscal 2014 Third Quarter Conference Call. Today's call is being recorded and webcast. For opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations, Mr. Dennis D'Andrea. Please go ahead, sir..

Good morning, everyone. On today's call are Fabrizio Freda, President and Chief Executive Officer; Tracey Travis, Executive Vice President and Chief Financial Officer; and Cedric Prouvé, Group President of International for The Esteé Lauder Companies. Cedric will discuss strategy and current results for key markets outside of North America.

Since many of our remarks today contain forward-looking statements, let me refer you to our press release and our reports filed with the SEC, where you'll find factors that could cause actual results to differ materially from these forward-looking statements.

Our discussion of our financial results and our expectations are before restructuring and other charges, including a remeasurement charge related to Venezuela.

In addition, we will discuss results before the impact of accelerated retail orders that took place in the prior year quarter due to the implementation of our Strategic Modernization Initiative and the impact on our full year expectations of accelerated retail orders expected in the quarter ending June 30, 2014.

You can find reconciliation between GAAP and non-GAAP figures in our press release and on the Investor Relations section of our website. And with that, I'll turn it over to Fabrizio..

Thank you, Dennis. Good morning, everyone. I'm pleased to report that our successful track record continued in the third quarter of fiscal 2014 as our strategy helped us deliver excellent results. We have generated sustainable, profitable and uninterrupted year-over-year sales growth quarter after quarter for nearly 5 years.

This achievement has been driven by our superb creativity and innovation, broad portfolio of prestige beauty brands, a business that's well diversified across categories, countries and channels and the flexibility to direct our investments to the best opportunities.

In the third quarter, our sales rose 12% in local currency, slightly higher than our estimate. Diluted earnings per share before charges were $0.64, ahead of our forecast and up 42% from a year ago. Our strong performance came from leveraging our sales and rebalancing our marketing activities.

We continue to be financially disciplined, with the flexibility to support strong growth areas while managing more prudently in others. As a reminder, last year third quarter sales reflected a shift of $94 million of accelerated orders into the second quarter in advance of our SAP rollout.

Adjusting for the shift, our underlying local currency sales gain this quarter would have been 8%. That increase is approximately double the annual growth of prestige beauty, which we estimate will be 3% to 4% this year. Global prestige beauty continues to benefit from favorable demographics and attracting new consumers from mass.

With our single focus on prestige beauty on a worldwide view into consumer trends identified by our 10-year compass, we have positioned our company in many of the fastest-growing and largest areas, making us confident we can continue outpacing the industry overall.

With 30 brands and more than 10 distribution channels around the globe, virtually every part of our business can fuel our growth. Depending on local economies, the cadence of our innovation and changing consumer desires, various brands, categories, regions and channels can be star performers.

The key for us is recognizing we're succeeding and being flexible, so as market dynamics change, we react quickly and put greater resources into the best opportunities, which has allowed us to excel and gain share globally.

Over the course of the year, we rely on all parts of our business to drive our sales growth, but the contribution from our multiple engines will vary by quarter. For example, during the first quarter of fiscal year 2014, China, our luxury brands and online drove much of our growth.

In the second quarter, the U.S., U.K., makeup, travel retail and online led the way. In the third quarter, our emerging markets, Europe, M-A-C and our luxury brands accounted for much of our sales gains. Having many growth engines is one of our best attributes and illustrates the breadth and the depth of our business.

They provide balance and reduce the risk of being overly dependent on any one part of our business to achieve sustainable, profitable growth. Our industry leadership was recently confirmed by a leading global market research firm.

It reported that in calendar 2013, we strengthened our position by adding 20 basis points of share, reinforcing our status as the #1 company worldwide in total prestige beauty.

We gained share in prestige skin care and makeup on a total global basis, as well as in some key markets and regions, demonstrating the strengths of our resource and location choices. Being nimble has allowed us to deliver strong results despite several challenging markets.

Looking at our product categories, skin care and makeup remain our priorities since they account for the vast majority of our business and present the largest opportunities. Our skin care growth this quarter was significantly higher than last year's third quarter and also improved sequentially.

We launched several important kinds of innovation to strengthen our global offering in this category. We are deploying more incremental innovation in areas where we either don't have a presence or our presence is limited.

Examples of these white-space products are watery lotions, which are a key part of Asian skin care regimens and a large category in the region. Seizing an opportunity, several of our brands introduced products to fill this locally relevant segment. These lotions are just rolling out in Asia, and early results are very encouraging.

Clinique's Even Better Essence Lotion has been the brand's biggest launch in Japan in more than a decade. It launches in China this quarter. Estée Lauder launched a high-performance product called Micro Essence Skin Activating Treatment Lotion. With its unique positioning as an essence in lotion, it has performed exceptionally well.

La Mer introduced its own watery lotion a few months ago, and it continues to exceed our expectations.

At the same time, we are protecting and modernizing our core franchises with the latest technology to keep them fresh and competitive, as we did with Clinique new Dramatically Different Moisturizing Lotion+ and the Estée Lauder brand improved Advanced Night Repair Serum. They have performed in line with our goals.

A third type of innovation we have been undertaking is bringing our brands into large existing categories they are not yet in. For instance, in this quarter, La Mer rolled out its Lifting Contour Serum and Lifting and Firming Mask, which comprised its first collection to address contouring and lift.

Our makeup category also was strong, reflecting consumer's growing appetite for the newness products, which plays into many of our brands' strengths. This is especially valuable for M-A-C, which introduces something new just about every week, such as a product, color story, collaboration or locally relevant collection.

This constant creativity gives it a competitive advantage. In the third quarter, there was a dramatic surge in lipsticks as M-A-C lipstick sales at retail climbed 25% in the U.S. prestige department stores. Lipsticks also helped lift the Estée Lauder brand's makeup results.

It's new Pure Color Envy Sculpting Lipstick collection, which features sophisticated packaging and intense pigments, was a huge success, particularly in North America and European region. Smashbox had a terrific quarter, thanks to strong demand for its new Full Exposure Eye Palette and selective distribution expansion internationally.

Our luxury fragrance brands, Jo Malone and Tom Ford, turned in an outstanding performance again, with double-digit gains in every region. Estée Lauder's new Modern Muse has resonated strongly with consumers. Among our new designer fragrance offerings, Tory Burch and the Michael Kors collection are the big success stories, exceeding our expectations.

And sales of our Zegna Essenza collection had been strong. As a company, we achieved our goal of gaining share in fragrance in the U.S. in the third quarter on strong profitable sales, with most of our brands contributing. In hair care, products from Aveda's Dry Remedy franchise helped drive strong increases internationally, and sales to salons rose.

Looking at our business by geography, we are the #1 prestige beauty player in many of the biggest markets, including the United States, the United Kingdom and Hong Kong, and also in some of the most important emerging markets such as China, South Africa and Brazil.

Our growth is well balanced between established markets and developing ones, which provides another layer of stability. All of our regions had sales growth for the quarter, as well as the fiscal year-to-date. This quarter, we continue to grow our business in the U.S. and China, however, less than in the past because of softness in these countries.

Despite the softness in these important markets, we still delivered strong growth as a company overall, which is another testament to the power of our diverse and broad portfolio and our strengths in many other markets. In North America, the retail environment was tough in the quarter due in part to severe weather in much of the U.S.

and a late Easter. China remains our biggest emerging market priority, and we are confident that long-term fundamentals remain strong. Despite an expected decline in same-store sales, our strategy to expand distribution, bring in new brand and enter more cities, continue to be solid.

In fiscal year '14, our company expects another year of double-digit sales growth in China, a trend we expect to continue over the long term. Aside from China, our other emerging market, which encompass 13 countries, grew healthy double digits combined, and their global total sales are bigger than our China business.

Consumers in these countries comprise an important part of our travel retail business. The fastest-growing in this important group of emerging market were Brazil, Turkey and Central Europe. Our sales in the U.K. continue to be vibrant, and our business in most Western European countries is improving as prestige beauty is showing growth.

Cedric will discuss our international business in more detail in a few minutes. Our goal of sustainably generating sales growth ahead of the industry is an outgrow of our compass, which identifies and validates promising areas of consumer interest and short-term trends.

Some products stemming from the vision will launch in the coming months, including breakthrough innovation to bring incremental business. For instance, Clinique plans to introduce 2 state-of-the-art global product in the first quarter of fiscal year '15.

One is a custom-fit serum that uses highly advanced technology to treat the ageless consumers in a way Clinique hasn't addressed before, incorporating a breakthrough formula. Clinique Smart Custom-Repair Serum is the brand's first serum that acts on different skin problem and on individual skin types.

The other product, a cleansing system that includes a new sonic device, was created by Clinique scientists working closely with the brand's guiding dermatologist and is rooted in the brand's skin care authority.

Clinique has more than 15,000 consultants around the world, and they are excited about selling the new system and educating consumer about its unique benefits. Esteé Lauder, meanwhile, is launching a new skin care product line in a big Asian white space.

Nutritious Rosy Prism incorporates proprietary technology to address skin discoloration that can be caused by aging and environmental pollution. These are just a few highlights of our outstanding creativity. Our innovation pipeline is strong and sustainable, and many other brands have exciting new products and services on the horizon.

With regard to our distribution, we sell our products in more than 10 channels, including salons, specialty multi and freestanding stores. These channels present varying degrees of opportunities worldwide for many of our brands.

One of our highest growth channel is our travel retail business, where we are the clear global leader in skin care and makeup, the fastest-growing beauty areas in the channel. We have gained share in these areas in recent years and still see many avenues of growth, including more brands, more airports and greater conversion of travelers into buyers.

Another winning channel for us continues to be our e-commerce business, which, again, grew double digits. We have been launching brand size in several of our emerging markets and keeping ahead of consumer shopping patterns by continuing to grow our mobile platforms.

We also have other opportunities to eliminate known added-value costs, and we will have greater visibility into area of saving and efficiencies once SAP is fully deployed. Tracey will provide more detail on these areas in a few minutes.

With just 2 months left in fiscal 2014, we expect to achieve our goals of 6% to 7% local currency sales growth for the full year. Based on results to date and our confidence in the future, we are raising our earnings per share estimates to $2.86 to $2.90 before charges.

These estimates exclude the impact of our next SAP go-live shift, which Tracey will also address. We will provide guidance for fiscal 2015 during our year-end call in August. At that time, we will also update our operating margin goals for the next 3 years.

I'm pleased to report that we are progressing faster than expected toward our current target of a 16.5% operating margin by the end of fiscal year '16. Now I will turn the call over to Cedric, who will discuss our international business..

one, developed markets are improving; two, turnaround markets are stabilizing; and three, emerging markets are growing. Developed markets represent the majority of our business, and it continued to grow. Several areas have been economically challenged in the recent years, notably Western Europe and Japan.

Encouragingly, we're seeing improvement across these economies in our business. In the third quarter, we grew share in Europe, where Germany had an excellent quarter and France, Italy and Spain all posted net sales growth, as well as retail growth ahead of prestige cosmetics.

Two key strategies for growth have been the diversification of our channel mix in the region and the accelerated growth of our more selective brands.

Our channel mix has evolved ahead of our objectives for fiscal '14, allowing us to generate nearly 20% of our sales directly to consumer through our own retail stores and online, up from 15% in fiscal '13.

Consequently, we have gained share in prestige beauty in developed Western European market this year, with growth at 2.8% compared to prestige beauty declining by 1.4%, or a gain of 50 basis points in share. Our U.K. business continued to perform strongly.

For the third quarter, our retail sales grew over 12%, continuing the solid improvement we've seen all year. This is even more impressive when you consider that The Esteé Lauder Companies is the top-ranked corporation in prestige beauty in the U.K., with share over 25%, led by Clinique as the #1 prestige brand. Our strategy in the U.K.

and Ireland is to leverage our very balanced portfolio and to treat these countries as emerging markets.

For example, we are pursuing new opportunities for our brands within this diversified consumer base in underserved neighborhoods in big and mid-tier cities where there is room for further penetration and locally relevant products and communications.

In Japan, we experienced strong retail growth this past quarter, as expected, in anticipation of a 3 percentage point increase in local VAT effective April 1. We are already experiencing encouraging trends this fiscal year, with retail growth of about 4% through December.

We anticipate that some of the VAT effect will reverse in Q4, but we expect mid-single-digit retail sales growth in Japan for the full fiscal year. Our strategies for Japan have been based on improved consumer insights and locally relevant innovation, laying the groundwork for continued growth.

Fabrizio mentioned the success of our recent introductions in the watery lotion category. In fact, we're the leading international company in our distribution in Japan. The second central theme is that turnaround markets are stabilizing. A few markets have been challenged recently, and we are pleased that they are now stabilizing and improving.

Both retail and net sales continued to be strong in Russia, a market where we are now more diversified than ever in terms of geography, brands and distribution. We are focused on diversifying our distribution more profitably and with greater stability.

We have been expanding our freestanding stores and online businesses while partnering more strategically with our retailers. Despite the general economic slowdown in Russia, we expect to outperform prestige beauty for the first fiscal year -- for the full fiscal year. We continue to monitor the crisis in Ukraine.

However, the market is not a large portion of the Russia business, and we have seen very little in the way of impact. The potential risk stems more from the possible escalation of sanctions between the U.S. and Russia.

Korea remains challenging, but the decline experienced in the past couple of years has slowed dramatically, and prestige beauty is stabilizing, with retail growth inching upward. Our business in Korea has seen sequential improvement, and for the third quarter, sales were relatively flat.

Most of our brands registered growth in Q3, reflecting a greater focus on brand portfolio execution. We continue to recover in Australia, a key market for us. Australia's GDP growth forecast reflects an improved outlook for consumer spending. Our retail performance shows sign of a turnaround, with growth in each quarter this year.

Nearly all of our brands grew in the quarter, mainly by strong double digits, and we are capturing share and recording solid growth on a [indiscernible] basis. Australian consumers' affinity with makeup, in particular, has benefited M-A-C, which we expect will finish the year as the leading prestige brand in the country.

The third central theme is that emerging markets continue to be a key building block for our international growth. China remains a strategic priority, and Greater China and Chinese consumers are a focus of the entire company. Our business in China continues to be strong, and there is plenty of additional expansion potential mid to long term.

While we experienced a slowdown in January and February due to competitive discounting for the Chinese New Year holiday, we recovered nicely in March, and our net sales are currently up 11% year-to-date without playing the promotional game.

We expect double-digit growth to continue in this market, where we have very productive doors in Tier 1 and Tier 2 cities and continue to expand beyond. We continue to expand geographically in China into new cities.

Fiscal year-to-date, our net sales in Tier 3 and 4 cities contributed 11% of brick-and-mortar retail, up from less than 8% in the year earlier, driven by Estée Lauder and Clinique. We continue to launch locally relevant products and introduce new brands, as evidenced by the opening of our first Jo Malone store in Beijing 6 weeks ago.

We have identified additional brands in our portfolio that could soon enter the market. Online is reshaping China's retail landscape. Our online sales are doubling on a fiscal year-to-date basis via our own brand sites, retailer sites and the incremental contribution of our Tmall initiative.

Clinique has been very successful with its online shop on Tmall, becoming the top prestige beauty brand official store. And Estée Lauder plans to go live there later this month, followed closely by Origins. Though China remains a strategic imperative, it is not our only emerging market focus.

Beyond China, there are more than a dozen markets which we also classify as emerging, and they are receiving varying degrees of investments, depending on the perceived opportunity. Today, these markets' combined sales exceed those of China and are growing double digits.

We envisioned that they will increasingly contribute well into our 10-year compass projections. For example, our business continues to grow double digits in Turkey, Russia, Brazil and Mexico, 4 of our more strategically important emerging markets, and we are growing share in each.

We have strong growth in South Africa, and we plan -- and we have plans to expand into additional markets on the African continent. Our Middle East business continues to be very exciting, with retail growth in excess of prestige beauty over the past few months.

Despite Venezuela, Latin America continues to perform with excellence and delivers faster growth than any of other regions. One way that affluent consumers from emerging markets are introduced to our brands is through the travel channel.

Our business in travel retail continues to grow nicely, with retail growth up 9% year-to-date against traffic growth estimated at 5%.

While Chinese-driven traffic has been challenged since October, when new tour regulations were implemented, we saw a significant improvement during the Chinese New Year period in January and February, driven mostly by independent travelers.

We keep investing in the channel by opening new brands and new doors, updating existing doors and maintaining a leading advertising presence in key airports.

Our strength in the APAC region and our ability to grow the emerging traveling consumer segment have led to our growth and considerable share gains in prestige skin care and makeup in the past 5 years. We are now the clear market leader in these categories and continue to add distance between us and our competitors.

We continue to implement our winning strategies by building new capabilities specific to the channel. As a key component to our SMI wave 4, the travel retail team is finalizing preparations for the July go-live.

We are confident the implementation of SAP in the channel will go smoothly and that we will be able to leverage it to improve our profitability through efficiency gains and value creation. The outlook for travel retail remains positive. International passenger traffic is expected to rise mid-single digit for the remainder of 2014.

We are well positioned to capitalize on this growth and further expand our brands in this most dynamic channel. Our online business continues to grow in importance.

This quarter, we launched 9 e-commerce sites around the world, including M-A-C in Brazil, which is exceeding expectations and is already positioned to be one of our top M-A-C doors in the coming year. We also launched 13 new m-commerce sites, including 3 in China for Clinique, La Mer and Origins.

In closing, I would like to stress that we are very confident about the future sustainability of the international contributions to the company's top and bottom line growth.

Our strategic focus on fostering better consumer insights, leveraging innovation, expanding our geographic presence, rolling out our brand portfolio, diversifying our channels and building new capabilities for success is working well.

Our continued ability to expand our international business and grow share speaks volumes about the strength of our brand -- brands, the strategic diversification of our market portfolio and our ability to collectively reach and touch consumers around the world. Now I will turn the call over to Tracey..

Thank you, Cedric, and good morning, everyone. I will first review our third quarter financial performance and then share our outlook for the remainder of fiscal '14. As a reminder, my commentary excludes the year-over-year impact of restructuring and other charges, primarily the Venezuela remeasurement charges on this morning's press release.

Reported net sales for the third quarter rose 11% to $2.55 billion, above the top end of our expectations. Excluding the impact of currency translation, sales grew 12%. Net earnings and diluted earnings per share each rose 42% to $251.7 million and $0.64, respectively.

EPS was also above the top end of our expectations due to both the sales performance and greater efficiency from our marketing investments.

Our third quarter sales growth was affected by the prior year acceleration of retailer orders into our second quarter that otherwise would have occurred in our third quarter related to the January 2013 rollout of SMI.

The impact of that shift in the prior year quarter was $94 million in sales and $78 million in operating income, equal to approximately $0.13 per share. Excluding the impact of the SMI-related order shift and restructuring and other charges, local currency sales would have grown 8% for the quarter and EPS would have grown 10%.

As I walk you through the highlights of our third quarter results, my commentary will exclude the impact of the SMI shift in the prior year's quarter, as well as other charges to facilitate easier comparison of our business performance. Looking at our sales growth by region.

Net sales in our Americas region increased 7% in local currency, with 6% growth in North America and 13% growth in Latin America.

Regarding softer retail sales, as Fabrizio indicated, a combination of challenging weather, a shift in gift timing for Clinique to the fourth quarter at a major retailer and anniversary-ing the 53rd week from last year along with Easter all contributed to retail performance.

The strongest channel performance in North America came from specialty multi-brand stores and online, while department stores and our freestanding stores were more reflective of the softer retail environment.

Latin American growth came primarily from double-digit increases in Brazil and Mexico, which saw strong growth at retail and the launch of M-A-C's e-commerce site in Brazil. These gains were partially offset by price reductions in Venezuela, mandated by the new margin cap law enacted at the end of January.

In the Europe, Middle East and Africa region, sales increased a strong 10% in local currency. Regional growth was led by a double-digit increase in the U.K. and 7% growth in travel retail. We also achieved double-digit growth in emerging markets such as Turkey, Russia and Eastern Europe.

Our markets in Western Europe were up across the board, with particular strength in Germany, Switzerland and Italy. France rose low single digits, and we saw encouraging growth in both Spain and in Greece. Our sales in the Asia/Pacific region increased 6% in local currency.

Japan led growth in the region, with high-teens growth largely driven by consumers who bought ahead of the April VAT increase. Taiwan, Australia and Singapore also experienced strong growth.

Sales in China rose low single digits for the quarter, reflecting a like-door decline of 7% and due to the increased promotional environment and growth in both online and offshore consumer shopping, as Cedric mentioned in his remarks. We added distribution in 5 doors and 1 new city in China this quarter.

Korea continues to stabilize, with sales declining less than 1%. Our gross margin decreased 40 basis points to 80.4%, which primarily reflected both a mix impact, as well as some promotional costs and obsolescence. Operating expense decreased 180 basis points to 65.5% of sales.

The major factors contributing to the decrease were flattish marketing costs driving expense leverage of approximately 170 basis points and leverage of general and administrative expenses of 30 basis points, partially offset by higher store operations expenses.

Flat marketing dollars in the quarter reflect both a rebalancing by quarter to match brand initiatives and greater support behind brands with primarily in-store, digital and print marketing models such as our makeup artist brands. Operating income rose 18% to $380.1 million, and operating margin increased 140 basis points to 14.9%.

Our effective tax rate on the adjusted earnings I just discussed was 31.4%. In our third quarter, we reported a remeasurement loss of $38.3 million related to changes in exchange rate regulations in Venezuela that occurred during the quarter.

The Venezuelan government approved a new currency exchange rate mechanism, SICAD II, for access by companies operating in a broader group of industry sectors than previous rates had been recently.

Our net monetary assets were converted from the previous official rate of VEF 6.3 to the new SICAD II exchange rate of VEF 49.81 per dollar as of March 31, resulting in the charge reflected in the quarter. Prior to the charge, Venezuela represented less than 1% of our year-to-date sales and less than 2% of our operating income.

For the 9 months, cash flow from operating activities rose 25% to $1.2 billion, primarily reflecting improvements in accounts payable and accounts receivable. Inventory days to sell rose to 191 compared with 165 days last year.

Higher inventory was mainly due to anticipated sales growth, increased safety stock to maintain appropriate service levels and the anticipation of accelerated orders into the fourth quarter related to the rollout of SMI.

For the 9 months, we have also invested $343 million in capital projects primarily to support new counters, technology and retail stores. We repurchased approximately 9 million shares of our stock for $600 million and used $225 million of cash to pay quarterly dividends to stockholders.

Our share repurchase program is open-ended, allowing us to buy back shares opportunistically. The acceleration in share buybacks in the third quarter reflected this policy, and we plan to continue this strategy when we have excess cash available in the U.S. As you know, a significant portion of our cash is offshore.

That said, in the past couple of years, we have used 100% of our available cash to return to shareholders through both share repurchases and dividends. Let's now turn to our outlook for the remainder of the fiscal year. We expect fiscal 2014 sales to grow between 6% and 7% in constant currency, in line with the growth we have experienced year-to-date.

Currency translation is expected to negatively impact our full year sales growth by approximately 1 percentage point. Our estimate assumes weighted average exchange rates for the full year of 1.36 for the euro, 1.62 for the pound and 1.01 for the yen.

The combined benefits of gross margin expansion and operating leverage are expected to improve operating margin by 60 to 70 basis points for the full year. Marketing expenditures are expected to increase approximately 3%, and other SG&A costs are expected to leverage.

Our continued cost management programs enable us to continue investing in long-term growth drivers like innovation, retail stores, e-commerce and information systems that support our company's future while reducing non-value-added costs. Our fiscal 2014 tax rate is planned at approximately 31%.

I'm pleased to say that we are raising our forecast for full year EPS to a range of $2.86 to $2.90 before the Venezuela remeasurement charge and the effect of the accelerated sales orders ahead our SMI go-live in July.

Depending on the magnitude of exchange rate movements, the approximately 1 percentage point negative currency impact on our top line equates to about $0.02 of EPS. The next wave of our SMI rollout is scheduled for July 2014 and will include our North American order-to-cash process, our travel retail business, Japan and the Middle East.

As has been the case in previous rollouts, retailers are expected to increase their orders in advance of the go-live to mitigate any potential disruptions from the transition. The impact will be to shift sales and profits into our fiscal 2014 fourth quarter and full year from our fiscal '15 first quarter and full year.

We estimate the shift in sales to be between $125 million and $150 million, equal to EPS of approximately $0.14 to $0.17.

This amount is higher than previous waves due both to the relative size of the businesses affected and to the higher expected sales in July compared to the timing of previous shifts, which have reflected seasonally slower periods in January.

Therefore, including the shift, our sales growth for the year is expected to be between 6% and 7%, and EPS is forecasted at $3 to $3.70 -- $3.07. With the July rollout, we will have completed our final major wave of SMI and will have more than 90% of our sales SAP-enabled.

We are excited about the opportunity to leverage the new systems and processes for further operational efficiencies and value creation.

We expect to see some of these greater efficiencies in our cost-saving programs in the areas of indirect procurement, improved inventory management with reduced levels and handling costs, productivity and cost of goods. We also continue to make progress on our marketing effectiveness initiatives.

In closing, we are very proud of the results we have achieved thus far this year. And on behalf of the entire management team, I would like to thank all of our employees for their tremendous dedication and hard work. And that concludes our prepared remarks this morning. We'll be happy to take your questions now..

[Operator Instructions] Our first question today comes from Mark Astrachan with Stifel..

I guess one sort of housekeeping question and one other question.

So China, could you maybe just give us a bit of your thoughts on what the category growth looks like and sort of try to put the slowdown in retail sales and in your same-store sales in terms of the context around category? And then, Cedric, sort of broadly speaking longer term, how do you think about the percentage of sales that you see coming from this company from developing markets over the next few years? And what do you think the number is, as we sit here today, inclusive of the percentage of sales that you got from travel retail that comes from developing markets?.

Okay. That's not one question. So I'll answer first the category, while Cedric will answer the rest. So we -- overall, the prestige industry, we see it growing 3% to 4%. And in the previous year, it's been growing at 4% to 5%, so this is a softer year of growth for global prestige beauty.

This is driven by -- continue to be driven by demographic, middle class, aging population. But the softness versus previous year in big markets, particularly in China and U.S., is what, at this point in time, is keeping the category around 3% to 4%. Between categories within prestige beauty, we continue to see skin care as a strong, growing category.

But this year, we see a special acceleration globally of the makeup category that become more and more important over time as a promising category within prestige beauty.

Now Cedric, do you want to address the international part?.

Yes, so if I understood the question, you're asking how we think the emerging market mix is going to evolve in the future. We have a pretty robust process where we have established a framework for all of our '13, '14 emerging markets, looking at them through 2022.

I don't have the exact number in mind, but what I would tell you is that with the CAGR that we are experiencing with these emerging markets, we expect that we would probably double their size in the next 4, 5 years. And I think you asked a question about travel retail. Travel retail fundamentals remain very strong.

And as we see these emerging populations accessing to travel and we are really growing in key populations that are going to travel increasingly, whether it's the Chinese or the Russians or Middle East or Turkey or Brazilians, so we are seeing an impact not only in the market but, of course, the destination.

We think we also have a project on travel retail that would take us to doubling the sales..

Your next question comes from Chris Ferrara with Wells Fargo..

I guess, Tracey, I know you've talked before about the ability to access working capital opportunities, particularly inventory days that you'd need, the final wave of SAP to be up and going.

So I guess the question is, with it likely to be 90%-plus done following this next wave, can you access working capital opportunities for this coming holiday season, or do you think it's more of a '15, '16 holiday season opportunity? And if so, just any preliminary thoughts on what you'd do with that cash as it starts to come through would be great..

Great question. So yes, I mean, clearly, the buildup that we saw in this quarter was to support that last major wave of SMI. And certainly, the higher levels that we've carried over the last couple of years have somewhat been driven by the rollout of SMI.

So we expect inventory levels to start to steadily come down in fiscal '15, which will certainly free up more cash for us. As I said in my prepared remarks, as we look at our free cash flow, we'd look at the mix of distribution to shareholders that is excess -- outside of any acquisitions that we might be planning to do to redistribute.

And that certainly will be what we do in the coming months when we believe we will have even more free cash flow available..

And your next question will come from the line of John Faucher with JPMorgan..

I want to talk a little bit about the marketing efficiency in the quarter.

What drove that? How is it -- is it sustainable as you look at it? Is that one of the reasons why you feel like you've got more confidence in the margin targets? And then there has been some chatter about sort of gift-with-purchase being maybe a little less efficient right now.

Are you seeing any of that in the market? So that issue specifically as well..

Yes. On marketing, I'll -- so yes, there is more efficiency that we are making, and there are several things driving the efficiency. First of all, we have an internal project, which is adjusting our investment measured with greater return on these investments.

So for example, we are adjusting down some of our television advertising activities and up other areas like digital and in-store and print as a result of some of these learnings that we had across initiatives. So this is about increasing rate of return on every single penny we spend.

Second, the overall percent that you save on marketing can be impacted by the kind of innovation we have. For example, if we launch a big innovation in skin care on our big brands like Lauder or Clinique, this tends to be carrying more advertising investment than some of our makeup artist brands.

So the mix between innovation across brands has an impact. Second, the mix by country has an impact. There are some countries which are more advertising-driven such as U.S. and other countries which are less advertising-driven such as some of the emerging markets.

So overall, given the mix evolution of our business, given our rate of return improvements, we are confident that we can leverage our marketing expenses, still continue to spend more against our key opportunity and initiatives. In terms of gift-with-purchase, yes, we see the gift-with-purchase being less efficient than what it used to be in the past.

That's why we are evolving and learning how to adjust our promotional strategy and how also, frankly, to improve the existing gift-with-purchase activity to make them more efficient for the future and more effective. Tracey, I don't know if you want to add something..

Yes, the only thing I'll add to that is that for the full year, we expect our marketing expense as a percent of sales to be slightly leveraged, so you won't see 170 basis points every quarter.

But to Fabrizio's point, it does depend on the brand launch activity and the brand support activity, obviously, but we do expect to see a slight leverage this year, full year..

And your next question will come from the line of Olivia Tong with Bank of America Merrill Lynch..

Just following up on the advertising and the spending support, it sounds like over time, natural progression, more emerging markets, more makeup artist brands and more of the luxury brands, that there's a natural pull for the advertising to come down.

So can you help us understand what -- help quantify what that kind of change is relative to what you can leverage in terms of just being more efficient?.

No. Frankly, I think it's very difficult to quantify because this will depend -- that's exactly what we are doing. As I said in my prepared remarks, we are trying to adjust our business, reflecting the opportunity around the world to being flexible to respond to the various opportunity as they evolve.

So it's very difficult to give you details at such level of complex mix element that we have around the world. But internal overall trend, you're right. That's exactly the point we are making. There is a leverage opportunity over time.

And the way we are programming our strategy, basically, we call it compass, the way we are working our 5-, 10-year vision and compass of our mix of countries, channels, brands is designed to leverage, to leverage our gross margin, to leverage our marketing expenses to become, over time -- and to go in the right direction.

However, you need to also assume that this change of model also bring new costs in some other aspect and areas of the P&L. For example, freestanding stores bring some other area of cost. And importantly, the mix -- the more we grow skin care globally, the more we can leverage all these aspects in our P&L..

And your next question comes from the line of Steve Powers with UBS..

Fabrizio, looking ahead, and I think you alluded to this in your prepared remarks and maybe in response to Chris's question, Tracey, earlier, but just given where the business is heading this fiscal year based on your guidance, should we expect you to revisit some of your longer-term goals alongside fiscal '15 guidance in a few months, whether with respect to the longer-term margin targets, working capital, the capital structure, cash deployment priorities in general.

Because I think beyond your ability to continue to grow and expand share amidst all of the competitive and macro challenges, just getting more clarity and confidence in what Estée Lauder thinks it can do longer term in terms of profitability and free cash flow generation is probably one of the highest-order questions for investors.

So just curious on how you're thinking about those items or at least a communication of them going forward..

So actually, yes, I have talked about that in my prepared remarks. And so we are progressing faster than what we expected toward our 16.5% margin for 16% previous goal. And so we expect to revise this goal in the August call, as we do every year. And so you will get, at that point, a new plan for the future.

We continue to believe that we have the ability to grow 0.5 margin point per year in the several future years, and that's what we are working on.

To do that, we will need to continue growing our business, to continue leveraging our business and importantly, as Tracey has explained in her remarks, to start using the SAP and the SMI project to creating value and to -- because we will have visibility on new value-added cost elimination opportunities.

Tracey, you want to add something?.

Yes. And the only thing I will add to that is one of the things that has worked incredibly well for us over the last few years is the opportunity to both identify and deliver cost savings, as well as invest for the future.

So much of what we are experiencing this year is related to investments that we have made in previous years to set up some of our midterm brands for more success, as an example. And we would expect to continue to do that over the next few years.

Certainly, SMI gives us a new tool to leverage cost savings, where -- versus some of the prior programs that we have. So we are, as I said in my prepared remarks, quite excited about moving forward in this next journey. We will update all of our goals in the August call. That will be margin, sales, as well as working capital.

And as the board authorizes capital structure, we'll update those goals as well..

And your next question comes from the line of Neely Tamminga with Piper Jaffray..

Quick housekeeping question for Tracey.

Could you just remind us the size and scope of your e-commerce business and kind of maybe whatever the high-level path of expansion you see for that channel? And then for Cedric, specifically, strategically, mobile commerce seems to be at a much faster adoption rate for your international consumers versus your U.S.

consumers based on the work that we do.

So as you look at your growth in digital for international, is it really, for you, more about sites, SKUs and brands available on those sites, or is it about key functionalities tied to payment that's going to drive conversion even further?.

So on your first question, our e-commerce business is approximately 6% of our total business. There are some markets that are more highly concentrated than others, so the U.S. and the U.K. have more developed e-commerce businesses, e-, m-commerce businesses. And in those markets, the percent of sales are about 10%.

And again, that includes both our sites, as well as our customer retailer sites. We are and have seen terrific growth in various markets of the e-commerce business. And certainly, Cedric talked about China, and I'll let him expand on the second part of your question in a moment.

And we invest where we see high adoption in terms of e- and m-commerce and where we see -- where we have a brand presence as well so that we can leverage both in-store visibility and consumer availability, as well as e- and m-commerce visibility..

Yes, so this is a big topic for international, but of course, we are very focused on the rollout of our sites around the world. You know the prospective now, it's 6% for total company. In some of our international markets, we are passing 10%, like the U.K. And in some of the emerging markets, we are, of course, in the very early stages of development.

In terms of the sites, it's important for us to develop the sites. We have our own sites, and we have retailer sites.

In general, what we see is that retailer sites tend to grow a little bit faster, so we have a program to actually help our retail partners developing their online business as well, because initially, there's always a little bit of reluctance and protection of their brick-and-mortar business.

What we see that's very important is the future of omni-channel, where actually, we need to integrate online and offline and we get much better consumer efficiency..

And the last part of your question was m-commerce. So our m-commerce in the quarter was just doubling versus last year. So you're right. The growth of m is really, really strong..

Much faster..

And your next question will come from the line of Alice Longley with Buckingham Research..

The organic sales growth in the quarter at 8%, how much do the early buying in Japan contribute to that? And a related question is that early buying clearly helped the quarter, but you were hurt by the promotional activity in China and in the U.S. by Easter, the weather and the Clinique shift.

So if we put all those things together, were you may be up 8% adjusted for those gives and takes?.

Yes, I would say with those gives and takes, we were up -- we were still up around 8%. So Japan, again, is a large market for us but in the whole scheme of things, from a total company standpoint, would not significantly impact our results -- our segment results, yes, not our total company results for the quarter..

Your 3 observations are correct. There has been some element of stocking these 3 things, but they are not significant numbers..

And your next question will come from the line of Jason English with Goldman Sachs..

This is Sean King in for Jason English. I guess the question that I have is if you could speak a little bit more about what you're seeing in U.S. department stores and what your expectation is for, I guess, the rest of the year given the weakness that we saw in the first quarter..

Yes, we saw a weak first quarter, as we explained, for several reasons, like weather, Easter and the 53rd week, et cetera. So what we see, we believe that we would see some recovery of the trend in the U.S. overall in the market. We are confident that the U.S.

market has the potential to continue growing in the mid-single digits for the long term and to continue growing faster than mass.

Within that, the mid-tier department stores are going to be the critical issue in terms of acceleration because, as you know, the rest of online, specialty, freestanding stores are, today, having strongest trend than mid-tier department stores.

But mid-tier department store acceleration is going to be supported by our innovation in the next 12 months, which is going to be strengthened, to be innovation, which is less cannibalizing. We call it white space innovation. It should bring new consumer and accelerate the trend again, particularly in the skin care area..

And your next question will come from the line of Ali Dibadj with Bernstein..

First, I just want a clarification on the 6% to 7% top line growth because until last quarter, that used to be excluding the SMI shift. And I'm trying to understand why now, it includes it, if I heard it correctly, particularly given the better number that you have from the top line for this quarter.

And then the non-clarification question, although I would like some clarification about it, is the skin care rebound looks pretty good at about 7%. And a lot of it sounds like it was from innovations, which didn't really materialize last quarter.

And I'm trying to understand -- I mean, cannibalization was a big theme last quarter for some of these innovations. I'm trying to understand why it's a little bit different this time, what went wrong last time, perhaps, what's getting better here.

And if you can rope in as well the context of the fact you're only spending 1% of your sales on R&D versus some of your competitors spending much, much more, as well as the fact that the margins in skin care look like they were down, that's why the operating income only grew 2%..

Okay, let me [indiscernible] for that question, Ali. In terms of the 6% to 7%, and again, we quoted a lot of numbers on the call with all of the moving parts, so I can understand some of the confusion. And I think the press release does a good job of laying it out when you can refer to it.

The 6% to 7% for the full year still does exclude the SMI shift. And obviously, we introduced the new SMI shift for the fourth quarter, but it also excludes that, so that is an SMI-adjusted number of 6% to 7%.

What we spoke about was the $125 million to $150 million of advanced shipments we'll see in our fourth quarter are worth about $0.14 to $0.17 of EPS growth for the year, but that is including the next SMI shift. But the 6% to 7% is clean of SMI..

So no change versus our previous 6% to 7%, so basically, we are not changing our full year 6% to 7% x SMI. And in terms of the skin care, so you're right, the skin care had a softer quarter in October, December, and now there is an acceleration.

The difference is the kind of innovation that we have in this part of the fiscal year is less cannibalizing. It's more white space. That's why in my prepared remarks, I spoke a lot about that exactly to make this point because I understood there was some confusion.

Our innovation going forward will be a good balance between revitalizing our historical SKUs, like Advanced Night Repair on Lauder, and then adding on top non-cannibalizing innovation that enter white space and creates more net extra and then bringing in some of our brands into areas they are not, which is again, non-cannibalizing.

So what you see in skin care is not necessarily more innovation in total, but you see that kind of innovation is driving faster growth. And I believe this will continue in the next 12 months, for example, with the innovation I have explained on Clinique in the course of my prepared remarks.

Then in terms of the -- what was the third question?.

R&D, 1%..

Yes, R&D 1% is -- we actually invest the majority of our R&D activity in skin care. So if you calculate the percent of your investment on the skin care sales, this is actually a higher number. That's one point. And then it's not necessarily apples-with-apples because we have other activities that support our innovation.

And last, we -- our innovation program is based a lot in connect and develop with other groups, meaning with the suppliers, with university, with other experts. So we leverage capabilities which are outside of the company with our R&D program in a very profound way..

And your next question comes from the line of Wendy Nicholson with Citi Research..

I just have really quick questions.

Number one, can you give us the like-door growth for China, whatever would be consistent with the minus 4% you gave us last quarter? And then, Tracey, on SMI, I know you've talked about how the first sort of aspect of the cost savings is just going to be turning off some of the legacy systems that you've been running sort of in duplicate as you've been in the process of rolling out SAP.

So can you quantify for us -- forget about above and beyond, process changes and real benefits from SMI and SAP, but just the turning off of that old system, when is that going to start, and how much is that going to equate to in terms of the benefit to margins?.

Okay. So for China, Wendy, the comp or the same-store sales growth in the quarter was minus 7%. And I mentioned in my prepared remarks that the total growth was low single digits, but the comp door sales growth was minus 7%. In terms of SMI and thinking about next year, so we go live in January.

We have our normal hyper care period for 3 months, so the team remains in place in order to support that activity. And then we can begin the process of decommissioning legacy systems. From a cost standpoint, I think we'll be able to update more holistically in August some of that activity.

There is some savings, though, related to your point of the decommissioning of those systems..

And your next question comes from the line of Caroline Levy with CLSA..

This is Brian Doyle in for Caroline. Just on the U.S. business, we were wondering if there was some shipping of new products maybe ahead of sell-through. The mid-single-digit growth in revenue was ahead of retail data that we've seen, which looked quite a lot weaker.

I know you had e-commerce, and owned stores did better, but if you could just help us out on that. And then secondly, I don't know if you actually commented on what you saw in terms of market share trend both in China and the U.S. in the quarter..

So on the shipments, you're correct. We did ship product in the U.S., particularly in the March time frame, to support some April activity. We talked about the Clinique gift that shifted into the fourth quarter from the third quarter, as well as some other activity as well. So that's why you see the disconnect in the third quarter.

And that's why we spoke about retail softness, although the numbers from a net standpoint didn't necessarily reflect that..

So what's the second question?.

Market share in U.S -- market share in U.S and China..

So the question on the U.S. market share is -- the answer, sorry, on the U.S. market share, we are, by far, the leader in the U.S. We're more than double the second competitor and around 39% overall share. When you look at our quarter and our year, we are doing a very solid results in makeup.

Also, please keep in mind that the retail numbers you see is only 60% of our business. The rest is not covered like freestanding store, online, et cetera. So the makeup, very solid. We are growing market share in fragrance and in hair care. We are growing faster than the market online in specialty, our luxury brands. So the specific issue in the U.S.

market share is skin care in mid-tier department stores, and we need to address this issue with the non-cannibalizing skin care innovation that we have been describing the course of this call, in our prepared remarks. That's exactly our plan.

That's exactly the area of focus that -- the area of softness that we will address with skin care innovation in the next 12 months to go back growing also skin care market share within prestige in the U.S..

And for China, we are the #1 group and we're the #1 brand. But we have stable market share for the year-to-date, and we lost a little bit of market share in the quarter..

And your next question comes from the line of Javier Escalante with Consumer Edge Research..

First, a clarification on what you mentioned in Japan. Could you remind us what percentage of sales the company has in Japan and what was the actual growth of Japan in the third quarter vis-à-vis the second quarter? That will be the clarification because I didn't understand what you said with the prior question.

And then more -- the real question has to do with China. The slowdown continued. What do you attribute this slowdown? Because we had seen a pickup of herbal and South Korean brands in our survey work.

And how that dovetails into your strategy of opening stores in China at a time that there seems to be a slowdown, what does it mean for margins to the extent that those points of distribution may not be having the kind of throughput that you may want to have?.

So I want first to address the China thing, and then we -- the Japan numbers. China, actually, it continued to be a very strong market. I want to clarify that slowdown means that it's gone from double-digit growth in the market to single-digit growth in the market but still remains one of the fastest-growing markets in the world.

Second point is China, the decline -- or the stabilization or market growth in Tier 1 city of China is what is seen in the number. Tier 2, Tier 3, Tier 4 cities continued to grow. China online business continued to grow, and China freestanding store and specialty channels continued to grow nicely. So the last point is on your issue of productivity.

China is still, today, the, by far, most productive market per door. Just a number -- our doors in China are 5x more productive on average than our doors in the U.S.

So a certain decrease on sales per door is to be expected with a strong increase in distribution that is happening and the fact that internal travelers, which are 350 million, now find the product in their city of origins, thanks to online and increased distribution in Tier 2 and Tier 3.

So the decline of same-door sales in China is expected and, by the way, will not impact profitability for many years to go because, as I said, it's the most productive market per door of the world as we speak. And the other....

So on Japan, Javier, both Cedric and I spoke about Japan. It's about 4% of our total sales. The market has been performing strongly this year up until, certainly, the third quarter, where obviously, the sales growth accelerated. So even prior to the VAT increase, Japan had been up mid-single digits.

In the third quarter, Japan was up high double digits, and that is in advance of, obviously, the April VAT increase, where the VAT went from 5% to 8%.

So Cedric spoke about a little bit of softness post VAT in the April time frame, but we would expect that Japan would recover to that mid-single-digit level based on some of the strong programs that we have in the market right now with Clinique and others..

And your next question comes from the line of Bill Schmitz with Deutsche Bank..

Sort of long, convoluted question, but part of the issue in the U.S., could it be -- I know a huge source of growth has been taking brands -- taking share away from some of the mass market brands.

And one of your competitors said there's no such thing as affordable luxury, meaning that we're going to focus our business almost exclusively on luxury products because there's sort of no mid-tier. And I think maybe part of the risk -- you can tell me if you think I'm dead wrong.

But the middle-class consumer is massively stretched right now, and you see it in some of the IRI-type data. And so is there a risk with the strategy of pulling people out of mass because that consumer, at least for the time being, is very at risk? Or maybe you think I'm being short-term on this, and over time, obviously, that market comes back.

Just love some clarification, if you don't mind..

Frankly, I think it's a great question because it's actually true that in this moment, meaning the last 6, 9 months, has been tougher to move people from mass into prestige than it used to be. In fact, you see also in our portfolio the growth of luxury brands is much stronger than the entry price of prestige brands.

And in fact, that's why, again, in our prepared remarks, we are explaining that we are turning our focus more balanced into gaining market share within prestige with the kind of innovation we are launching also and a non-cannibalizing one. That, however, is, as you say, a short-term point, meaning that's what is the right to do in this moment.

I believe, frankly, that in the long term, the sourcing from mass strategy will continue to be the way to grow the category in prestige, that the middle-class growth will fuel the prestige market. Now in the U.S., this may be slower than in this moment than in other markets, but globally, this is still the clear trend, even today in total.

So you're right, but I don't think this is a long-term trend. I think this is just a short-term U.S.-specific adjustment that, in fact, we are doing..

Your final question will come from the line of Nik Modi with RBC Capital Markets..

Fabrizio, I was wondering maybe if you can just touch on the -- one of the earlier questions on emerging markets.

And as you think about the 10-year compass and doubling the business over the next 5 years, how should we think about the margin profile? Because many consumer companies see margin degradation as they expand more aggressively in emerging markets. So if you can provide any clarity there, that would be really helpful..

No. Actually, as we explained in the last years, in the majority of our emerging markets, we start to build a business in a way which is accretive and not dilutive to the other -- to the company after a certain amount of year of investment, obviously.

So the growing level of the profitability in the emerging markets tends to be in line or accretive to the margin, so we don't see an issue of this kind. Also, the expansion of international contains an important share of travel retail and online.

And as you know, those will continue to be among the fastest segments in the international growth, and they are very profit-accretive. And finally, within the emerging market, we tend to choose and prioritize the ones which are more accretive and the brands that we use to build emerging markets. Take this is mind in a very important way.

So net, I don't believe the expansion of new channel and new emerging market will be a dilutive risk. If anything, it's one of the mix element that, over time, will play in favor of building our profitability..

Holly, can we wrap up?.

Yes. If you were unable to join for the entire call, a playback will be available at 1 p.m. Eastern Time today through May 16. To hear a recording of the call, please dial (855) 859-2056, passcode 30824577. That concludes today's Estée Lauder conference call. I'd like to thank you all for your participation and wish you all a good day..